...
首页> 外文期刊>Cancer biology & therapy >MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition
【24h】

MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition

机译:通过DNA甲基转移酶3B基因抑制,MiR-339,尤其是miR-766重新激活大肠癌细胞系中抑癌基因的表达

获取原文
获取原文并翻译 | 示例
           

摘要

It is observed that upregulation of DNMT3B enzyme in some cancers, including colon cancer, could lead to silencing of tumor suppressor genes. MiR-339 and miR-766 have been predicted to target 3'UTR of DNMT3B gene. Luciferase reporter assay validated that individual and co-transfection of miR-766 and miR-339 into the HEK293T cell reduced luciferase activity to 26% +/- 0.41%, 43% +/- 0.42 and 64% +/- 0.52%, respectively, compared to the control (P < 0.05). Furthermore, transduction of miR-339 and miR-766 expressing viruses into colon cancer cell lines (SW480 and HCT116) decreased DNMT3B expression (1.5, 3-fold) and (3, 4-fold), respectively. In addition, DNA methylation of some tumor suppressor genes decreased. Expression of these genes such as SFRP1 (2 and 1.6-fold), SFRP2 (0.07 and 4-fold), WIF1 (0.05 and 4-fold), and DKK2 (2 and 4-fold) increased in SW-339 and SW-766 cell lines; besides, expression increments for these genes in HCT-339 and HCT-766 cell lines were (2.8, 4-fold), (0.005, 1.5-fold), (1.7 and 3-fold) and (0.04, 1.7-fold), respectively. Also, while in SW-766, cell proliferation reduced to 2.8% and 21.7% after 24 and 48 hours, respectively, SW-339 showed no reduced proliferation. Meanwhile, HCT-766 and HCT-339 showed (3.5%, 12.8%) and (18.8%, 33.9%) reduced proliferation after 24 and 48 hours, respectively. Finally, targeting DNMT3B by these miRs, decreased methylation of tumor suppressor genes such as SFRP1, SFRP2, WIF1 and DKK2 in the mentioned cell lines, and returned the expression of these tumor suppressor genes which can contribute to lethal effect on colon cancer cells and reducing tumorigenicity of these cells.
机译:据观察,在包括结肠癌在内的某些癌症中,DNMT3B酶的上调可能导致肿瘤抑制基因沉默。已预测MiR-339和miR-766靶向DNMT3B基因的3'UTR。萤光素酶报告基因检测证实,将miR-766和miR-339单独和共转染到HEK293T细胞中,萤光素酶活性分别降低到26%+/- 0.41%,43%+/- 0.42和64%+/- 0.52% ,与对照组相比(P <0.05)。此外,将表达miR-339和miR-766的病毒转导到结肠癌细胞系(SW480和HCT116)中,DNMT3B表达分别降低(1.5、3倍)和(3、4倍)。另外,一些肿瘤抑制基因的DNA甲基化降低。这些基因的表达,例如SFRP1(2和1.6倍),SFRP2(0.07和4倍),WIF1(0.05和4倍)和DKK2(2和4倍)在SW-339和SW- 766个细胞系;此外,这些基因在HCT-339和HCT-766细胞系中的表达增量分别为(2.8、4倍),(0.005、1.5倍),(1.7和3倍)和(0.04、1.7倍),分别。同样,在SW-766中,细胞增殖分别在24和48小时后降低到2.8%和21.7%,而SW-339没有显示出降低的增殖。同时,HCT-766和HCT-339在24和48小时后分别显示出(3.5%,12.8%)和(18.8%,33.9%)的增殖减少。最后,通过这些miR靶向DNMT3B,降低了上述细胞系中肿瘤抑制基因(如SFRP1,SFRP2,WIF1和DKK2)的甲基化,并返回了这些肿瘤抑制基因的表达,这些基因可能对结肠癌细胞具有致死作用并降低这些细胞的致瘤性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号